NCT05620186 PROficiency Based StePwise Endovascular Curricular Training: Multicentric Registry
| NCT ID | NCT05620186 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Vascular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2017-10-17 |
| Primary Completion | 2027-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2017-10-17 with a primary completion date of 2027-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this multicentric registry is to gather data from trainees completing PROSPECT: a PROficiency Based StePwise Endovascular Curricular Training to obtain basic cognitive and technical skills. The main goals are to identify if: * Results from a previous randomised controlled trail can be reproduced in real life. * Evaluate skills retention after program completion. * Assess real life implementation of the training program.
Eligibility Criteria
Inclusion Criteria: * Surgical trainee * Knowledge and technical skill level evaluated * Demographics questionnaire and general MCQ test completed * Endovascular simulated exercise completed after familiarization with the simulator Exclusion Criteria: * N/A
Contact & Investigator
Isabelle Van Herzeele, MD, PhD
PRINCIPAL INVESTIGATOR
University Hospital, Ghent
Frequently Asked Questions
Who can join the NCT05620186 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Vascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05620186 currently recruiting?
Yes, NCT05620186 is actively recruiting participants. Contact the research team at isabelle.vanherzeele@ugent.be for enrollment information.
Where is the NCT05620186 trial being conducted?
This trial is being conducted at Ghent, Belgium, Leuven, Belgium, Copenhagen, Denmark.
Who is sponsoring the NCT05620186 clinical trial?
NCT05620186 is sponsored by University Hospital, Ghent. The principal investigator is Isabelle Van Herzeele, MD, PhD at University Hospital, Ghent. The trial plans to enroll 120 participants.